CogniAid™ | Stuðningur við minni, einbeitingu og hugræna virkni | Heilsubarinn

CogniAid™ | Stuðningur við minni, einbeitingu og hugræna virkni

9.990 kr

CogniAid™ | Stuðningur við minni, einbeitingu og hugræna virkni

9.990 kr

CogniAid™ | Stuðningur við minni, einbeitingu...

9.990 kr

• Inniheldur Bacopa Monnieri, Memophenol™ (Grape & Wild Blueberry Extract), NooGandha® Ashwagandha, American Ginseng og Huperzine-A
• Styður við minni, einbeitingu og hugræna virkni
• Stuðlar að eðlilegu jafnvægi í taugakerfi og andlegri orku
• Plöntuefni sem styðja eðlilegt varnarkerfi frumna
• Hentar vel við nám, hugræna vinnu og daglega andlega virkni
• Glútenlaust, mjólkurlaust, soyalaust og óerfðabreytt

Frí sending yfir 15 þúsund krónur. Pantanir eru afgreiddar samdægurs ef pantað er fyrir kl. 13, annars daginn eftir (virka daga). Ekki er afgreitt um helgar. Þær eru afhentar með Dropp, á þann stað sem þú velur.

Örugg greiðslulausn með Saltpay eða Netgíró.

Auðveld skil með Dropp.

Nánari Lýsing

CogniAid™ frá Designs for Health er jurtablanda sem styður við heilastarfsemi, minni og einbeitingu. Formúlan sameinar jurtir og plöntuútdrætti sem hafa lengi verið notaðir til stuðnings við andlega virkni og hugarorku.

Blandan inniheldur Bacopa Monnieri, Memophenol™ (Grape & Wild Blueberry Extract), NooGandha® Ashwagandha Extract, American Ginseng og Huperzine-A. Þessi virku næringarefni og jurtasambönd taka þátt í eðlilegri boðleið heilans og styðja við skýra hugsun, minni og jafnvægi í taugakerfi.

Grape og Blueberry útdrættir innihalda náttúruleg plöntuefni sem styðja við eðlilega frumuvörn. Bacopa og Ashwagandha hafa verið notaðar í Ayurvedískri nálgun til stuðnings einbeitingu, minni og daglegri hugrænni virkni.

CogniAid™ hentar þeim sem vilja styðja við einbeitingu, minni og andlega orku sem hluta af heilsusamlegum lífsstíl.

Fyrir hvern er varan?

• Fyrir þá sem vilja styðja minni og einbeitingu
• Fyrir þá sem vinna hugrænt krefjandi starf eða nám
• Fyrir einstaklinga sem vilja styðja ró og andlega skerpu
• Fyrir þá sem sækjast eftir jurtamiðaðri heila- og vellíðunarblöndu

ÍTARLEGRI UPPLÝSINGAR

Taktu 2 hylki á dag með máltíðum eða samkvæmt leiðbeiningum heilbrigðisstarfsmanns.

1. Xu ZQ, Liang XM, Juan-Wu, Zhang YF, Zhu CX, Jiang XJ. Treatment with huperzine A improves cognition in vascular dementia patients. Cell Biochem Biophys. 2012;62(1):55-58. doi:10.1007/s12013-011-9258-5.

2. Ha GT, Wong RK, Zhang Y. Huperzine a as potential treatment of Alzheimer’s disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodivers. 2011;8(7):1189-1204. doi:10.1002/cbdv.201000269.

3. Zheng W, Xiang YQ, Li XB, et al. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis. Hum Psychopharmacol. 2016;31(4):286-295. doi:10.1002/hup.2537.

4. Ratia M, Giménez-Llort L, Camps P, et al. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer’s disease in triple transgenic mice (3xTg-AD). Neurodegener Dis. 2013;11(3):129-140. doi:10.1159/000336427.

5. Gul A, Bakht J, Mehmood F. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer’s disease. J Chin Med Assoc. 2019;82(1):40-43. doi:10.1016/j.jcma.2018.07.004.

6. Cai Y, Huang P, Xie Y. Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia. Acta Cir Bras. 2020;34(12):e201901205. doi:10.1590/s0102-865020190120000005.

7. Yang G, Wang Y, Tian J, Liu JP. Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013;8(9):e74916. doi:10.1371/journal.pone.0074916.

8. Sukumaran NP, Amalraj A, Gopi S. Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst – a review on its mechanistic aspects. Complement Ther Med. 2019;44:68-82. doi:10.1016/j.ctim.2019.03.016.

9. Kean JD, Downey LA, Stough C. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement Ther Med. 2016;29:56-62. doi:10.1016/j.ctim.2016.09.002.

10. Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313-326. doi:10.1089/rej.2013.1431.

11. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. 2014;28(4):551-559. doi:10.1002/ptr.5029.

12. Abdul Manap AS, Vijayabalan S, Madhavan P, et al. Bacopa monnieri, a neuroprotective lead in alzheimer disease: a review on its properties, mechanisms of action, and preclinical and clinical studies. Drug Target Insights. 2019;13:1177392819866412. doi:10.1177/1177392819866412.

13. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528-535. doi:10.1016/j.jep.2013.11.008.

14. Downey LA, Kean J, Nemeh F, et al. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance. Phytother Res. 2013;27(9):1407-1413. doi:10.1002/ptr.4864.

15. Pase MP, Kean J, Sarris J, Neale C, Scholey AB, Stough C. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012;18(7):647-652. doi:10.1089/acm.2011.0367.

16. Ma L, Sun Z, Zeng Y, Luo M, Yang J. Molecular mechanism and health role of functional ingredients in blueberry for chronic disease in human beings. Int J Mol Sci. 2018;19(9):2785. doi:10.3390/ijms19092785.

17. Lamport DJ, Lawton CL, Merat N, et al. Concord grape juice, cognitive function, and driving performance: a 12-wk, placebo-controlled, randomized crossover trial in mothers of preteen children.  Am J Clin Nutr. 2016;103(3):775-783. doi:10.3945/ajcn.115.114553.

18. Tan L, Yang HP, Pang W, et al. Cyanidin-3-O-galactoside and blueberry extracts supplementation improves spatial memory and regulates hippocampal ERK expression in senescence-accelerated mice. Biomed Environ Sci. 2014;27(3):186-196. doi:10.3967/bes2014.007.

19. Mohan S, Gobinath T, Salomy A, et al. Biophysical interaction of resveratrol with sirtuin pathway: significance in Alzheimer’s disease. Front Biosci (Landmark Ed). 2018;23:1380-1390. doi:10.2741/4650.

20. Hein S, Whyte AR, Wood E, Rodriguez-Mateos A, Williams CM. Systematic review of the effects of blueberry on cognitive performance as we age. J Gerontol A Biol Sci Med Sci. 2019;74(7):984-995. doi:10.1093/gerona/glz082.

21. Krikorian R, Boespflug EL, Fleck DE, et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem. 2012;60(23):5736-5742. doi:10.1021/jf300277g.

22. Boespflug EL, Eliassen JC, Dudley JA, et al. Enhanced neural activation with blueberry supplementation in mild cognitive impairment. Nutr Neurosci. 2018;21(4):297-305. doi:10.1080/1028415X.2017.1287833.

23. McNamara RK, Kalt W, Shidler MD, et al. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-156. doi:10.1016/j.neurobiolaging.2017.12.003.

24. Miller MG, Hamilton DA, Joseph JA, Shukitt-Hale B. Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial. Eur J Nutr. 2018;57(3):1169-1180. doi:10.1007/s00394-017-1400-8.

25. Devore EE, Kang JH, Breteler MM, Grodstein F. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012;72(1):135-143. doi:10.1002/ana.23594.

26. Whyte AR, Cheng N, Butler LT, Lamport DJ, Williams CM. Flavonoid-rich mixed berries maintain and improve cognitive function over a 6 h period in young healthy adults. Nutrients. 2019;11(11):2685. doi:10.3390/nu11112685.

27. Bowtell JL, Aboo-Bakkar Z, Conway ME, Adlam AR, Fulford J. Enhanced task-related brain activation and resting perfusion in healthy older adults after chronic blueberry supplementation. Appl Physiol Nutr Metab. 2017;42(7):773-779. doi:10.1139/apnm-2016-0550.

28. Lee J, Torosyan N, Silverman DH. Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: a double-blinded placebo controlled pilot study. Exp Gerontol. 2017;87(pt A):121-128. doi:10.1016/j.exger.2016.10.004.

29. Bensalem J, Dudonné S, Etchamendy N, et al. Polyphenols from grape and blueberry improve episodic memory in healthy elderly with lower level of memory performance: a bicentric double-blind, randomized, placebo-controlled clinical study. J Gerontol A Biol Sci Med Sci. 2019;74(7):996-1007. doi:10.1093/gerona/gly166.

30. Barfoot KL, May G, Lamport DJ, Ricketts J, Riddell PM, Williams CM. The effects of acute wild blueberry supplementation on the cognition of 7-10-year-old schoolchildren. Eur J Nutr. 2019;58(7):2911-2920. doi:10.1007/s00394-018-1843-6.

31. Haskell-Ramsay CF, Stuart RC, Okello EJ, Watson AW. Cognitive and mood improvements following acute supplementation with purple grape juice in healthy young adults [published correction appears in Eur J Nutr. October 6, 2017]. Eur J Nutr. 2017;56(8):2621-2631. doi:10.1007/s00394-017-1454-7.

32. Choudhary D, Bhattacharyya S, Bose S. Efficacy and safety of ashwagandha (Withania somnifera (L.) dunal) root extract in improving memory and cognitive functions. J Diet Suppl. 2017;14(6):599-612. doi:10.1080/19390211.2017.1284970.

33. Dar NJ, MuzamilAhmad. Neurodegenerative diseases and Withania somnifera (L.): an update.  J Ethnopharmacol. 2020;256:112769. doi:10.1016/j.jep.2020.112769.

34. Pandey A, Bani S, Dutt P, Kumar Satti N, Avtar Suri K, Nabi Qazi G. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine. 2018;102:211-221. doi:10.1016/j.cyto.2017.10.019.

35. Ng QX, Loke W, Foo NX, et al. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother Res. 2020;34(3):583-590. doi:10.1002/ptr.6552.

36. Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.  J Clin Psychiatry. 2013;74(11):1076-1083. doi:10.4088/JCP.13m08413.

37. Szczuka D, Nowak A, Zakłos-Szyda M, et al. American ginseng (Panax quinquefolium L.) as a source of bioactive phytochemicals with pro-health properties. Nutrients. 2019;11(5):1041. doi:10.3390/nu11051041.

38. Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry. 2011;72(8):689-699. doi:10.1016/j.phytochem.2011.02.012.

39. Shin K, Guo H, Cha Y, et al. Cereboost™, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and neuroprotection. Regul Toxicol Pharmacol. 2016;78:53-58. doi:10.1016/j.yrtph.2016.04.006.

40. Chen EY, Hui CL. HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: a double-blind, placebo-controlled study. Phytother Res. 2012;26(8):1166-1172. doi:10.1002/ptr.3700.

41. Scholey A, Ossoukhova A, Owen L, et al. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl). 2010;212(3):345-356. doi:10.1007/s00213-010-1964-y.

42. Ossoukhova A, Owen L, Savage K, et al. Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefolius L.) to healthy middle-age adults. Hum Psychopharmacol. 2015;30(2):108-122. doi:10.1002/hup.2463.